YARROW BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-12-31 was 144.40K shares, a 14340.30% increase year-over-year.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-09-30 was 183.00 shares.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-06-30 was 25.75K shares.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-03-31 was 34.42K shares.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 70.83K shares.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 204.75K shares, a 19.76% decline from fiscal 2018.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 255.19K shares, a 1276.78% increase from fiscal 2017.
- YARROW BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2017 was 18.54K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2021-12-31 | 70.83K shares 10-K · filed 2022-03-17 | |
| 2019-12-31 | 144.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | 204.75K shares 10-K · filed 2020-03-03 |
| 2019-09-30 | 183.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | 61.35K shares derived: sum of 4 quarters · filed 2020-03-03 |
| 2019-06-30 | 25.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | |
| 2019-03-31 | 34.42K shares 10-Q · filed 2019-05-02 | |
| 2018-12-31 | 1.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | 255.19K shares 10-K · filed 2020-03-03 |
| 2017-12-31 | 18.54K shares 10-K · filed 2020-03-03 | |
| 2016-12-31 | 0.00 shares 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |